|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hironaka N, Mochida K, Mori N, Maeda M,
Yamamoto N and Yamaoka S: Tax-independent constitutive IkappaB
kinase activation in adult T-cell leukemia cells. Neoplasia.
6:266–278. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prasad S, Ravindran J and Aggarwal BB:
NF-kappaB and cancer: How intimate is this relationship. Mol Cell
Biochem. 336:25–37. 2010. View Article : Google Scholar
|
|
4
|
Claudius AK, Kankipati CS, Kilari RS,
Hassan S, Guest K, Russell ST, Perry CJ, Stark LA and Nicholl ID:
Identification of aspirin analogues that repress NF-κB signalling
and demonstrate anti-proliferative activity towards colorectal
cancer in vitro and in vivo. Oncol Rep. 32:1670–1680.
2014.PubMed/NCBI
|
|
5
|
Yang H, Qi H, Ren J, Cui J, Li Z, Waldum
HL and Cui G: Involvement of NF-κB/IL-6 pathway in the processing
of colorectal carcinogenesis in colitis mice. Int J Inflam.
2014:1309812014. View Article : Google Scholar
|
|
6
|
Thu YM, Su Y, Yang J, Splittgerber R, Na
S, Boyd A, Mosse C, Simons C and Richmond A: NF-κB inducing kinase
(NIK) modulates melanoma tumorigenesis by regulating expression of
pro-survival factors through the β-catenin pathway. Oncogene.
31:2580–2592. 2012. View Article : Google Scholar :
|
|
7
|
Thu YM and Richmond A: NF-κB inducing
kinase: A key regulator in the immune system and in cancer.
Cytokine Growth Factor Rev. 21:213–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Annunziata CM, Davis RE, Demchenko Y,
Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W,
et al: Frequent engagement of the classical and alternative
NF-kappaB pathways by diverse genetic abnormalities in multiple
myeloma. Cancer Cell. 12:115–130. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao JL and Starczynowski DT: Role of
microRNA-146a in normal and malignant hematopoietic stem cell
function. Front Genet. 5:2192014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: microRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wang K, Wang G, Ba Y, et al: Role of miR-143
targeting KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Wu H, Li P, Zhao Y, Liu M and
Tang H: NF-κB-modulated miR-130a targets TNF-α in cervical cancer
cells. J Transl Med. 12:1552014. View Article : Google Scholar
|
|
13
|
Liu Z, Gersbach E, Zhang X, Xu X, Dong R,
Lee P, Liu J, Kong B, Shao C and Wei JJ: miR-106a represses the Rb
tumor suppressor p130 to regulate cellular proliferation and
differentiation in high-grade serous ovarian carcinoma. Mol Cancer
Res. 11:1314–1325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abdelmohsen K, Srikantan S, Kuwano Y and
Gorospe M: miR-519 reduces cell proliferation by lowering
RNA-binding protein HuR levels. Proc Natl Acad Sci USA.
105:20297–20302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farhana L, Dawson MI, Murshed F, Das JK,
Rishi AK and Fontana JA: Upregulation of miR-150* and
miR-630 induces apoptosis in pancreatic cancer cells by targeting
IGF-1R. PLoS One. 8:e610152013. View Article : Google Scholar
|
|
16
|
Guo J, Li M, Meng X, Sui J, Dou L, Tang W,
Huang X, Man Y, Wang S and Li J: MiR-291b-3p induces apoptosis in
liver cell line NCTC1469 by reducing the level of RNA-binding
protein HuR. Cell Physiol Biochem. 33:810–822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Odqvist L, Sánchez-Beato M, Montes-Moreno
S, et al: NIK controls classical and alternative NF-κB activation
and is necessary for the survival of human T-cell lymphoma cells.
Clin Cancer Res. 19:2319–2330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li M, Wang X, Liu M, Qi X and Li J: NF-κB
signaling inhibition and anticancer activities of LLDT-246 on human
colorectal cancer HCT-116 cells in vitro. Biomed Pharmacother.
68:527–535. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hajder J, Marisavljević D, Stanisavljević
N, Mihaljević B, Kovcin V, Marković O and Zivković R: BCL10
aberations and NF-kappa B activation involving p65 are absent or
rare in primary gastric MALT lymphoma. Vojnosanit Pregl.
71:1040–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Celegato M, Borghese C, Casagrande N,
Carbone A, Colombatti A and Aldinucci D: Bortezomib down-modulates
the survival factor interferon regulatory factor 4 in Hodgkin
lymphoma cell lines and decreases the protective activity of
Hodgkin lymphoma-associated fibroblasts. Leuk Lymphoma. 55:149–159.
2014. View Article : Google Scholar
|
|
21
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kupcinskas J, Bruzaite I, Juzenas S,
Gyvyte U, Jonaitis L, Kiudelis G, Skieceviciene J, Leja M, Pauzas
H, Tamelis A, et al: Lack of association between miR-27a, miR-146a,
miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal
cancer. Sci Rep. 4:59932014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rodríguez-Montes JA and Menéndez Sánchez
P: Role of micro-RNA in colorectal cancer screening. Cir Esp.
92:654–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valeri N, Gasparini P, Braconi C, Paone A,
Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, et al:
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating
human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA.
107:21098–21103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang CJ, Stratmann J, Zhou ZG and Sun XF:
Suppression of microRNA-31 increases sensitivity to 5-FU at an
early stage, and affects cell migration and invasion in HCT-116
colon cancer cells. BMC Cancer. 10:6162010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boni V, Bitarte N, Cristobal I, Zarate R,
Rodriguez J, Maiello E, Garcia-Foncillas J and Bandres E:
miR-192/miR-215 influence 5-fluorouracil resistance through cell
cycle-mediated mechanisms complementary to its post-transcriptional
thymidilate synthase regulation. Mol Cancer Ther. 9:2265–2275.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Sun X, Wang Y, Liu X, Xuan Y and
Hu S: Association between miR-27a genetic variants and
susceptibility to colorectal cancer. Diagn Pathol. 9:1462014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Yang MH, Wang XY, Lin J and Ding
YQ: Increased expression of miRNA-182 in colorectal carcinoma: An
independent and tissue-specific prognostic factor. Int J Clin Exp
Pathol. 7:3498–3503. 2014.PubMed/NCBI
|
|
29
|
Huh JH, Kim TH, Kim K, Song JA, Jung YJ,
Jeong JY, Lee MJ, Kim YK, Lee DH and An HJ: Dysregulation of
miR-106a and miR-591 confers paclitaxel resistance to ovarian
cancer. Br J Cancer. 109:452–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Plummer SM, Holloway KA, Manson MM, Munks
RJ, Kaptein A, Farrow S and Howells L: Inhibition of
cyclo-oxygenase 2 expression in colon cells by the chemopreventive
agent curcumin involves inhibition of NF-kappaB activation via the
NIK/IKK signalling complex. Oncogene. 18:6013–6020. 1999.
View Article : Google Scholar : PubMed/NCBI
|
